| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income (loss) from continuing operations | 4,990 | 25,713 | -38,514 | -59,770 |
| Loss from discontinued operations, net of tax | -54 | -1,826 | -49 | -47 |
| Net income (loss) | 4,936 | 23,887 | -38,563 | -59,817 |
| Preferred stock dividends | 162,185 | 0 | 162,185 | 162,185 |
| Net loss available to common stockholders | -157,249 | 23,887 | -200,748 | -222,002 |
| Income loss available to common stockholders - basic | 0 | 0 | -0.01 | -0.01 |
| Income loss available to common stockholders - diluted | 0 | 0 | -0.01 | -0.01 |
| Weighted average number of shares outstanding - basic | 33,372,796 | 33,372,796 | 33,372,796 | 32,903,493 |
| Weighted average number of shares outstanding -diluted | 33,372,796 | 38,667,862 | 33,372,796 | - |
VYCOR MEDICAL INC (VYCO)
VYCOR MEDICAL INC (VYCO)